Literature DB >> 23981796

Methylphenidate-placebo: a trial for attention deficit disorders.

K Tenreiro1.   

Abstract

Entities:  

Year:  2001        PMID： 23981796

Source DB:  PubMed          Journal:  Int J Pharm Compd        ISSN： 1092-4221


× No keyword cloud information.
  3 in total

1.  Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder.

Authors:  Fariba Arabgol; Leily Panaghi; Paria Hebrani
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-06-18       Impact factor: 4.785

2.  A comparison of the effects of reboxetine and placebo on reaction time in adults with Attention Deficit-Hyperactivity Disorder (ADHD).

Authors:  F Hashemian; S Mohammadian; F Riahi; P Ghaeli; D Ghodsi
Journal:  Daru       Date:  2011       Impact factor: 3.117

3.  Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371].

Authors:  Shahin Akhondzadeh; Mohammad-Reza Mohammadi; Mojgan Khademi
Journal:  BMC Psychiatry       Date:  2004-04-08       Impact factor: 3.630
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.